InvestorsHub Logo
Followers 285
Posts 31200
Boards Moderated 0
Alias Born 07/06/2012

Re: Money_Tree post# 104382

Friday, 04/18/2014 4:19:38 PM

Friday, April 18, 2014 4:19:38 PM

Post# of 402214
Fair enough. Perhaps I threw up the wrong article then. This looks like the one I should've thrown up.

US Back Pain Market Approaches $23 Billion in 2018 - Anticipated Long-Acting,
Abuse-Resistant Opioids Drive Value

http://www.reuters.com/article/2009/03/23/idUS158167+23-Mar-2009+PRN20090323

The US back pain market for drug
treatment will be valued at almost $23 billion in 2018, according to US Back
Pain, a report released today by WWMR, Inc. Growth in this market will be
driven largely by the opioid agonist products that are currently in
development. Many of these are long-acting, abuse-resistant formulations that
are highly anticipated in the clinical community. If pipeline products
deliver on efficacy and safety, uptake is likely to be considerable and at
premium prices.



Fear Uncertainty and Doubt FUD It Ain't Going To Work Here Anymore. Notice the lack of question mark.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News